Cytomegalovirus hyperimmune globulin for CMV disease refractory to ganciclovir in renal transplantation
Waid, T.H.; McKeown, J.W.
Transplantation Proceedings 27(5 Suppl 1: 46
1995
ISSN/ISBN: 0041-1345 PMID: 7482820 Document Number: 439400
Document emailed within 1 workday
Related Documents
Bonaros, N.E.; Kocher, A.; Dunkler, D.; Grimm, M.; Zuckermann, A.; Ankersmit, J.; Ehrlich, M.; Wolner, E.; Laufer, Günther. 2004: Comparison of combined prophylaxis of cytomegalovirus hyperimmune globulin plus ganciclovir versus cytomegalovirus hyperimmune globulin alone in high-risk heart transplant recipients Transplantation 77(6): 890-897Uber, L.; Cofer, J.; Baliga, P.; Rajagopalan, P.R. 1995: Effectiveness of combination prophylaxis with cytomegalovirus hyperimmune globulin and acyclovir in the high-risk kidney transplant recipient Transplantation Proceedings 27(5 Suppl 1: 42-43
Shen, G.K.; Alfrey, E.J.; Knoppel, C.L.; Dafoe, D.C.; Scandling, J.D. 1997: Eradication of cytomegalovirus reactivation disease using high-dose acyclovir and targeted intravenous ganciclovir in kidney and kidney/pancreas transplantation Transplantation 64(6): 931-933
Horng, I.H.; Chen, M.S.; Lee, P.H.; Chen, Y.C.; Lee, C.S.; Hou, P.K. 1989: Cytomegalovirus retinitis treated with ganciclovir in a renal transplant recipient Journal of the Formosan Medical Association 88(11-12): 1152-1155
Dreikorn, K.; Doerr, H.W.; Geursen, R.G. 1985: Cytomegalovirus (CMV) infections in renal transplant recipients. Preliminary results of prophylaxis by an intramuscular human hyperimmune CMV IgG Scandinavian Journal of Urology and Nephrology. Supplementum 92: 15-21
Ratnamohan, V.M.; Chapman, J.; Howse, H.; Bovington, K.; Robertson, P.; Byth, K.; Allen, R.; Cunningham, A.L. 1998: Cytomegalovirus and human herpesvirus 6 both cause viral disease after renal transplantation Transplantation 66(7): 877-882
Conti, D.J.; Freed, B.M.; Lempert, N. 1993: Prophylactic immunoglobulin therapy improves the outcome of renal transplantation in recipients at risk for primary cytomegalovirus disease Transplantation Proceedings 25(1 Part 2): 1421-1422
Winston, D.J.; Ho, W.G.; Lin, C.H.; Bartoni, K.; Budinger, M.D.; Gale, R.P.; Champlin, R.E. 1987: Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation Annals of Internal Medicine 106(1): 12-18
Peraldi, M.N.; Rondeau, E.; Bellaj, A.; Kanfer, A.; Sraer, J.D. 1988: Association of cytomegalovirus infection and immunosuppressive treatment with cyclosporine A and antilymphocyte globulin in renal transplant recipients Clinical Nephrology 29(1): 52
Hochster, H.; Dieterich, D.; Bozzette, S.; Reichman, R.C.; Connor, J.D.; Liebes, L.; Sonke, R.L.; Spector, S.A.; Valentine, F.; Pettinelli, C. 1990: Toxicity of combined ganciclovir and zidovudine for cytomegalovirus disease associated with AIDS. An AIDS Clinical Trials Group Study Annals of Internal Medicine 113(2): 111-117
Van den Berg, A.P.; van Son, W.J.; van der Bij, W.; van der Giessen, M.; The, T.H. 1990: Early identification of patients at high risk of severe cytomegalovirus disease after renal transplantation using the immediate early antigenemia assay Transplantation Proceedings 22(4): 1800-1802
Guay, L.A.; Musoke, P.; Hom, D.L.; Nakabiito, C.; Bagenda, D.; Fletcher, C.V.; Marum, L.H.; Fowler, M.Glenn.; Falksveden, L.G.; Wahren, B.; Kataaha, P.; Wigzell, H.; Mmiro, F.A.; Jackson, J.Brooks. 2002: Phase I/II trial of HIV-1 hyperimmune globulin for the prevention of HIV-1 vertical transmission in Uganda Aids 16(10): 1391-1400
Novick, A.C. 1983: Uses of antilymphocyte globulin in renal transplantation Urologic Clinics of North America 10(2): 253-262
Calicó, I.; García, E.; Cortés, A.; Gavaldá, J.; Roman, A.; Valle, I. 1999: Strains of ganciclovir-resistant cytomegalovirus Enfermedades Infecciosas y Microbiologia Clinica 17(7): 330-334
Clark, K. 1996: Monitoring antithymocyte globulin in renal transplantation Annals of the Royal College of Surgeons of England 78(6): 536-540
Deodhar, S.D.; Konomi, K.; Nakamoto, S.; Kuruvila, K.C. 1971: Clinical experience with antilymphocyte globulin (ALG) in renal transplantation Transplantation Proceedings 3(1): 758-761
Snydman, D.R.; Werner, B.G.; Dougherty, N.N.; Griffith, J.; Rohrer, R.H.; Freeman, R.; Jenkins, R.; Lewis, W.D.; O'Rourke, E. 1994: A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection. Boston Center for Liver Transplantation CMVIG-Study Group Transplantation Proceedings 26(5 Suppl 1: 23-27
MacArthur, R.B. 1990: Ganciclovir: approved and investigational uses for the treatment of cytomegalovirus retinitis Mount Sinai Journal of Medicine new York 57(6): 378-380
Leman, J.S.; Toalson, T.W.; Wlodaver, C.G. 1997: Ganciclovir treatment of systemic cytomegalovirus in an immunocompetent host Journal of the Oklahoma State Medical Association 90(7): 367-369
Xu, Q.J. 1985: Prophylactic adjunctive use of antilymphocyte globulin in cadaveric renal transplantation Zhonghua Yi Xue Za Zhi 65(4): 215-217